Evidence map›Paper›PMID 28086866›Full record

ArticleBMC health services research2017

Perceptions and utilization of generic medicines in Guatemala: a mixed-methods study with physicians and pharmacy staff.

David Flood, Irène Mathieu, Anita Chary, Pablo García, Peter Rohloff

Open access · goldAbstract read
In one paragraph

Article in BMC health services research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
15.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Real-world comprehensive care of people living with schizophrenia: recommendations across different settings and clinical stages.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

David FloodWuqu' Kawoq | Maya Health Alliance, 2 Calle 5-43 Zona 1, Santiago Sacatepéquez, Guatemala. david@wuqukawoq.org.ORCID 0000-0002-4372-7387
Irène MathieuWuqu' Kawoq | Maya Health Alliance, 2 Calle 5-43 Zona 1, Santiago Sacatepéquez, Guatemala.
Anita CharyWuqu' Kawoq | Maya Health Alliance, 2 Calle 5-43 Zona 1, Santiago Sacatepéquez, Guatemala.
Pablo GarcíaWuqu' Kawoq | Maya Health Alliance, 2 Calle 5-43 Zona 1, Santiago Sacatepéquez, Guatemala.
Peter RohloffWuqu' Kawoq | Maya Health Alliance, 2 Calle 5-43 Zona 1, Santiago Sacatepéquez, Guatemala.
Probigua · GT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAccess to low-cost essential generic medicines is a critical health policy goal in low-and-middle income countries (LMICs). Guatemala is an LMIC where there is both limited availability and affordability of these medications. However, attitudes of physicians and pharmacy staff regarding low-cost generics, especially generics for non-communicable diseases (NCDs), have not been fully explored in Guatemala.

methodsSemi-structured interviews with 30 pharmacy staff and 12 physicians in several highland towns in Guatemala were conducted. Interview questions related to perceptions of low-cost generic medicines, prescription and dispensing practices of generics in the treatment of two NCDs, diabetes and hypertension, and opinions about the roles of pharmacy staff and physicians in selecting medicines for patients. Pharmacy staff were recruited from a random sample of pharmacies and physicians were recruited from a convenience sample. Interview data were analyzed using a thematic approach for qualitative data as well as basic quantitative statistics.

resultsPharmacy staff and physicians expressed doubt as to the safety and efficacy of low-cost generic medicines in Guatemala. The low cost of generic medicines was often perceived as proof of their inferior quality. In the case of diabetes and hypertension, the decision to utilize a generic medicine was based on multiple factors including the patient's financial situation, consumer preference, and, to a large extent, physician recommendations.

conclusionsInterventions to improve generic medication utilization in Guatemala must address the negative perceptions of physicians and pharmacy staff toward low-cost generics. Strengthening state capacity and transparency in the regulation and monitoring of the drug supply is a key goal of access-to-medicines advocacy in Guatemala.

Indexed as

Attitude of Health PersonnelConsumer BehaviorDrug CostsDrugs, EssentialDrugs, GenericFemaleGuatemalaHealth PolicyHumansMaleMiddle AgedPerceptionPharmaceutical ServicesPharmaciesPharmacistsPhysiciansDrugs, EssentialDrugs, GenericAccess to medicinesEssential medicinesGeneric medicinesGuatemalaMedicine perceptionsNon-communicable diseasesPharmacist roles

Identifiers

PMID28086866
PMCPMC5234139
OpenAlexW2573028588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.